Details for New Drug Application (NDA): 209599
✉ Email this page to a colleague
The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 209599
Tradename: | CHOLESTYRAMINE LIGHT |
Applicant: | Tagi |
Ingredient: | cholestyramine |
Patents: | 0 |
Pharmacology for NDA: 209599
Mechanism of Action | Bile-acid Binding Activity |
Suppliers and Packaging for NDA: 209599
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599 | ANDA | TAGI Pharma, Inc. | 51224-009 | 51224-009-10 | 201.6 g in 1 CAN (51224-009-10) |
CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599 | ANDA | TAGI Pharma, Inc. | 51224-009 | 51224-009-20 | 60 POUCH in 1 CARTON (51224-009-20) / 4.8 g in 1 POUCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/PACKET | ||||
Approval Date: | Nov 12, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/SCOOPFUL | ||||
Approval Date: | Nov 12, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription